Antiviral PROTACs: Opportunity borne with challenge
Open Access
- 27 March 2023
- journal article
- review article
- Published by Elsevier in Cell Insight
- Vol. 2 (3) , 100092
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81773557, 82073690, 82173676, 82273774)
- National Key Research and Development Program of China (2020YFA0908800)
- Fundamental Research Funds for the Central Universities (2042021kf1033)
This publication has 167 references indexed in Scilit:
- Viral Ancestors of Antiviral SystemsViruses, 2011
- Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1Journal of General Virology, 2011
- Nanoparticulate Delivery Systems for Antiviral DrugsAntiviral Chemistry and Chemotherapy, 2010
- Influenza Hemagglutinin and Neuraminidase Membrane GlycoproteinsJournal of Biological Chemistry, 2010
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug DevelopmentPharmaceuticals, 2010
- Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancerOncogene, 2008
- Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor TelaprevirGastroenterology, 2007
- What Is the Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical TrialsJournal of Clinical Oncology, 2006
- Severe Acute Respiratory Syndrome (SARS): A Year in ReviewAnnual Review of Medicine, 2005
- Transmissibility of 1918 pandemic influenzaNature, 2004